In addition we found that EZH1 p.A678G is equivalent to the cancer-associated EZH2-p.A677G variant, which modifies the substrate preference of EZH2 leading to a change in H3K27me0 to me3 kinetics that results in increased H3K27me3 levels43,44. The gene discussed is EZH1; the disease is cancer.